Literature DB >> 17133606

Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.

Francesca Margheri1, Mirko Manetti, Simona Serratì, Daniele Nosi, Marco Pucci, Marco Matucci-Cerinic, Bashar Kahaleh, Laura Bazzichi, Gabriella Fibbi, Lidia Ibba-Manneschi, Mario Del Rosso.   

Abstract

OBJECTIVE: In systemic sclerosis (SSc) microvascular endothelial cells (MVECs), angiogenesis is blocked by matrix metalloproteinase 12-dependent cleavage of domain 1 of the urokinase-type plasminogen activator receptor (uPAR). Since integrins are associated with the invasive activity of uPAR in angiogenesis, this study was undertaken to show whether full-size and truncated uPAR are differentially associated with integrins and with motor components of the cytoskeleton.
METHODS: SSc and normal MVECs were isolated from human skin biopsy specimens and studied by confocal laser scanning microscopy and immunoprecipitation to assess the mechanisms of association of truncated and full-size uPAR with integrins and the actin cytoskeleton. The integrin composition of the MVECs was studied by reverse transcription-polymerasechain reaction. Cell migration and capillary morphogenesis were studied on fibrinogen substrates. Involvement of Rac and Cdc42 was evaluated by Western blotting.
RESULTS: Only full-size uPAR showed a connection with the actin cytoskeleton in ECs. This connection was mediated by the uPAR-associated alphaMu- and alphaX-subunits of beta2 integrin, and was absent from SSc MVECs. The cleaved uPAR was not associated with beta2 integrins or with actin. beta3 integrins were associated with both the full-size and cleaved uPAR at focal contacts. The uncoupling of uPAR from beta2 integrins in SSc MVECs impaired the activation of Rac and Cdc42 (thus inhibiting their mediation of uPAR-dependent cytoskeletal rearrangements and cell motility) and blocked the integrin-engagement-delivered signals to the actin cytoskeleton. Invasion and capillary morphogenesis on fibrinogen-coated substrates indicated that ligation of uPAR by uPA empowers the beta2/beta3 integrin-dependent invasion of fibrinogen, and that this system is impaired in SSc MVECs.
CONCLUSION: The reduced angiogenic properties of SSc MVECs can be explained by the effects of uPAR truncation and the subsequent loss of the beta2 integrin-mediated connection of uPAR with the actin cytoskeleton in these ECs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133606     DOI: 10.1002/art.22263

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

Review 1.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

Review 2.  Pathogenesis of systemic sclerosis-current concept and emerging treatments.

Authors:  Masutaka Furue; Chikage Mitoma; Hiroki Mitoma; Gaku Tsuji; Takahito Chiba; Takeshi Nakahara; Hiroshi Uchi; Takafumi Kadono
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 3.  Is there evidence for vasculitis in systemic sclerosis?

Authors:  Lesley Ann Saketkoo; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 4.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

5.  Quantitative Proteomics Reveals β2 Integrin-mediated Cytoskeletal Rearrangement in Vascular Endothelial Growth Factor (VEGF)-induced Retinal Vascular Hyperpermeability.

Authors:  Dong Hyun Jo; Jingi Bae; Sehyun Chae; Jin Hyoung Kim; Jong-Hee Han; Daehee Hwang; Sang-Won Lee; Jeong Hun Kim
Journal:  Mol Cell Proteomics       Date:  2016-03-11       Impact factor: 5.911

Review 6.  Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts.

Authors:  Bradley J Rabquer; Alisa E Koch
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

7.  Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.

Authors:  Yoshihide Asano; Lukasz Stawski; Faye Hant; Kristin Highland; Richard Silver; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

Review 8.  Matrix metalloproteinases: a review of their structure and role in systemic sclerosis.

Authors:  Wen-jia Peng; Jun-wei Yan; Ya-nan Wan; Bing-xiang Wang; Jin-hui Tao; Guo-jun Yang; Hai-feng Pan; Jing Wang
Journal:  J Clin Immunol       Date:  2012-07-06       Impact factor: 8.317

Review 9.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

10.  Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice.

Authors:  Francesca Margheri; Simona Serratì; Andrea Lapucci; Chillà Anastasia; Betti Giusti; Marco Pucci; Eugenio Torre; Francesca Bianchini; Lido Calorini; Adriana Albini; Agostina Ventura; Gabriella Fibbi; Mario Del Rosso
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.